GlassScriptPhysician profile
Thomas A Coury
NPI 1770506370
$3,120.27
in general payments reported to CMS, 2019-2025
35 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $483 · 2020: $280 · 2021: $269 · 2022: $567 · 2023: $777 · 2024: $626 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,421 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,421.47 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $447.80 | 2019-2024 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $350.66 | 2019-2024 | Erleada, Akeega |
| C. R. Bard, INC. & Subsidiaries | $318.00 | 2023-2025 | Bard Urinary Drainage Bag, Personal Catheter Intermittent Catheter |
| Pfizer INC. | $238.25 | 2019-2025 | |
| Axonics, INC. | $187.57 | 2020-2024 | Axonics, Bulkamid |
| Coloplast Corp | $174.46 | 2019-2025 | Speedicath |
| Merck Sharp & Dohme LLC | $174.44 | 2022-2025 | Keytruda, Welireg, Lynparza |
| Myriad Genetic Laboratories, INC. | $154.11 | 2021-2023 | Prolaris |
| Endo Pharmaceuticals INC. | $106.00 | 2019-2024 | Xiaflex |
| Rochester Medical Corporation | $104.67 | 2019-2022 | |
| Teleflex LLC | $104.46 | 2022-2024 | Urolift |
| Abbvie INC. | $87.34 | 2022-2024 | Botox |
| Blue Earth Diagnostics | $71.97 | 2019-2021 | |
| Tolmar, INC. | $59.91 | 2023 | |
| 180 Medical, INC. | $56.15 | 2022-2024 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $52.08 | 2022-2023 | Lynparza |
| Bayer Healthcare Pharmaceuticals INC. | $38.37 | 2019-2022 | |
| Tolmar Pharmaceuticals, INC. | $33.46 | 2019-2022 | |
| Allergan, INC. | $32.28 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $32.20 | 2023-2024 | Orgovyx, Gemtesa |
| Amgen INC. | $31.22 | 2019-2022 | |
| Baxter Healthcare | $26.92 | 2019 | |
| Ambu INC. | $24.92 | 2023 | |
| Janssen Scientific Affairs, LLC | $24.64 | 2021 | |
| Myovant Sciences INC. | $23.93 | 2021 | |
| Accord Healthcare, INC. | $22.44 | 2022 | |
| Cook Medical LLC | $20.90 | 2022 | |
| Neotract INC. | $19.94 | 2020 | |
| Medtronic, INC. | $16.83 | 2021 | |
| Procept Biorobotics Corporation | $16.68 | 2022 | |
| Dentsply Ih Ab | $15.46 | 2023 | Lofric |
| Avadel Specialty Pharmaceuticals, LLC | $14.38 | 2019 | |
| Boston Scientific Corporation | $13.22 | 2024 | Ams 700 |
| Olympus America INC. | $13.01 | 2022 | |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Coury listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.